| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC10873 | CID16020046 Featured | CID 16020046 is a potent and selective GPR55(LPI receptor) antagonist; inhibitsGPR55 constitutive activity with IC50 of 0.15 uM. |
|
| DC22056 | CID 9998128 | CID 9998128 is a potential multi-target drug for the Alzheimer's disease (AD), inhibits the Aβ42 amyloid fibrillization and is capable to clear Aβ42 fibrils. |
|
| DC12243 | CID-1067700 | CID-1067700 is a pan GTPase inhibitor, and competitively inhibits Ras-related in brain 7 (Rab7) with a Ki of 13 nM. |
|
| DC7253 | CID-2011756 Featured | CID-2011756 is a cell-active ATP competitive and specific PKD1 inhibitor that inhibits phorbol ester-induced endogenous PKD1 activation in LNCaP prostate cancer cells. |
|
| DC8849 | CID-2858522 Featured | CID-2858522 is a selectively inhibits protein kinase C (PKC)-induced activation of the NF-κB pathway (IC50 < 0.1 μM for PMA-stimulated IL-8 production). |
|
| DC20895 | CID3528206 | CID3528206 is a potent, small molecule yeast TORC1 inhibitor that inhibits TORC1 activity both in vitro and in vivo with IC50 of 150 nM and 3.9 uM, respectively. |
|
| DC9955 | BCL6 inhibitor(CID5721353) Featured | CID5721353 is a B-Cell Lymphoma 6 Inhibitor (BCL6 inhibitor). |
|
| DC7385 | CID-755673 Featured | CID755673 is a potent and selective cell-active small molecule inhibitor for PKD with an IC50 of 182 nM; exhibits selective PKD1 inhibition when compared with AKT, PLK1, CAK, CAMKIIα, and PKC isoforms. |
|
| DC7976 | CID 797718 Featured | CID-797718 is a compound with unknown details. |
|
| DC23753 | CID888706 | CID888706 is a small molecule, pan activator of Rho-family GTPases.. |
|
| DC20904 | CIDD 0067106 | CIDD 0067106 is a novel natural product-based diaryloxazole that potent and selective antiproliferative activities against androgen receptor-positive breast cancer cells (MDA-MB-453 cell GI50=0.8 uM). |
|
| DCAPI1021 | Cidofovir(Vistide) Featured | Cidofovir(Vistide) |
|
| DC10839 | CIL56(CA3) Featured | CIL56 is a small molecule that induces cellular ferroptosis through production of iron-dependent reactive oxygen species (ROS). |
|
| DC11374 | Cilastatin | Cilastatin is an inhibitor of dipeptidase (dehydropeptidase I), a renal dipeptidase. |
|
| DCAPI1569 | Cilostazol | Cilastazol is a 2-oxo-quinoline with vasodilator, antimitogenic, antithrombotic, and cardiotonic properties. This compound has been shown to cause inhibition of adenosine uptake, eventually resulting in changes to cAMP levels. Studies have shown Cilostazo |
|
| DC9325 | Cilazapril (monohydrate) Featured | Cilazapril Monohydrate is a angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and congestive heart failure. |
|
| DC7561 | Cilengitide (TFA salt) Featured | Cilengitide is a potent integrin inhibitor for αvβ3 receptor and αvβ5 receptor with IC50 of 4.1 nM and 79 nM, respectively; ~10-fold selectivity against gpIIbIIIa. Phase 2. |
|
| DC9875 | Ciliobrevin A(HPI4) Featured | Ciliobrevin A(HPI-4) is a Hedgehog pathway inhibitor and ciliogenesis inhibitor. |
|
| DC20341 | Ciliobrevin D Featured | Ciliobrevin D is a cell-permeable, reversible, specific inhibitor of cytoplasmic dynein, blocks dynein-dependent microtubule gliding and ATPase activity while sparing kinesin dependent cellular trafficking. |
|
| DC9160 | Cilnidipine Featured | Cilnidipine(FRC8653) is a dual L- and N-type calcium channel blocker and displays antihypertensive, sympatholytic and neuroprotective activity. |
|
| DC10868 | Cilofexor Featured | Cilofexor (GS-9674, GS9674) is novel specific, non-steroidal farnesoid X receptor (FXR) agonist that reduces liver fibrosis and ameliorates portal hypertension in rat NASH models. |
|
| DC9582 | Cilomilast | Cilomilast(SB 207499; Ariflo) is a potent PDE4 inhibitor with IC50 of about 110 nM, has anti-inflammatory activity and low central nervous system activity. |
|
| DC22028 | Ciluprevir | Ciluprevir (BILN2061) is a potent HCV NS3/4A protease inhibitor with Ki of 0.66 and 0.30 nM for NS3-NS4A protease of HCV 1b and HCV 1a, respectively. |
|
| DC9002 | Cimetidine | Cimetidine is a histamine-2 (H2) receptor antagonist. |
|
| DC12134 | Cimiside B | Cimiside B, a glycoside alkaloid, isolated from the rhizome of Cimicifuga dahurica. |
|
| DC8801 | Cinacalcet (AMG-073) Featured | Cinacalcet(AMG-073) is an orally active, second-generation calcimimetic compound; AMG 073 represents a new class of compounds for the treatment of hyperparathyroidism. |
|
| DC12369 | Cinaciguat (hydrochloride) Featured | Cinaciguat is an activator of sGC that binds to a regulatory site, resulting in activation in an NO-independent manner (Kd = 3.2 nM). |
|
| DC20093 | Cinchonine ((8R,9S)-Cinchonine; LA40221) Featured | Cinchonine is a natural compound present in Cinchona bark. Cinchonine activates endoplasmic reticulum stress-induced apoptosis in human liver cancer cells. |
|
| DC9174 | Cinepazide maleate | Cinepazide Maleate is a vasodilator. |
|
| DC9896 | Cinnarizine Featured | Cinnarizine is a medication derivative of piperazine, and characterized as an antihistamine and a calcium channel blocker. |
|
